Copyright
©The Author(s) 2025.
World J Exp Med. Sep 20, 2025; 15(3): 107711
Published online Sep 20, 2025. doi: 10.5493/wjem.v15.i3.107711
Published online Sep 20, 2025. doi: 10.5493/wjem.v15.i3.107711
Table 4 Regression analysis for the diagnosis of epithelial ovarian cancer patients
| Odds ratio | 95%CI for Exp(B) | P value | ||
| Lower | Upper | |||
| Age | 1.103 | 1.049 | 1.159 | 0.001 |
| Family history | 0 | 0.00 | 0.00 | 0.999 |
| Menopausal status | 0 | 0.00 | 0.00 | 0.999 |
| Cancer antigen 125 | 1.072 | 1.025 | 1.122 | 0.002 |
| Human epididymis protein 4 | 1.069 | 1.030 | 1.111 | 0.001 |
| Insulin-like growth factors-binding proteins 2 | 1.009 | 1.000 | 1.017 | 0.044 |
| Thrombospondin 1 protein | 1.000 | 1.000 | 1.000 | 0.080 |
| Secreted phosphoprotein 1 | 1.375 | 1.092 | 1.732 | 0.007 |
| D-dimer | 1.674 | 0.000 | 3611171.830 | 0.945 |
- Citation: Ibrahim NH, Abdellateif MS, Serag DS, Laymouna A, Elaguizy MS, Halim RMA. Clinical significance of differential plasma proteins levels in the diagnosis of epithelial ovarian cancer. World J Exp Med 2025; 15(3): 107711
- URL: https://www.wjgnet.com/2220-315X/full/v15/i3/107711.htm
- DOI: https://dx.doi.org/10.5493/wjem.v15.i3.107711